Yildirim, N. Et Al. 2022. Evaluation of the relationship between intravascular hemolysis and clinical manifestations in sickle cell disease: decreased hemopexin during vaso-occlusive crises and increased inflammation in acute chest syndrome. ANNALS OF HEMATOLOGY , vol.101, no.1 , 35-41.

Yildirim, N., ÜNAL, S., Yalcinkaya, A., Karahan, F., & ER ÖZTAŞ, Y., (2022). Evaluation of the relationship between intravascular hemolysis and clinical manifestations in sickle cell disease: decreased hemopexin during vaso-occlusive crises and increased inflammation in acute chest syndrome. ANNALS OF HEMATOLOGY , vol.101, no.1, 35-41.

Yildirim, Nazim Et Al. "Evaluation of the relationship between intravascular hemolysis and clinical manifestations in sickle cell disease: decreased hemopexin during vaso-occlusive crises and increased inflammation in acute chest syndrome," ANNALS OF HEMATOLOGY , vol.101, no.1, 35-41, 2022

Yildirim, Nazim Et Al. "Evaluation of the relationship between intravascular hemolysis and clinical manifestations in sickle cell disease: decreased hemopexin during vaso-occlusive crises and increased inflammation in acute chest syndrome." ANNALS OF HEMATOLOGY , vol.101, no.1, pp.35-41, 2022

Yildirim, N. Et Al. (2022) . "Evaluation of the relationship between intravascular hemolysis and clinical manifestations in sickle cell disease: decreased hemopexin during vaso-occlusive crises and increased inflammation in acute chest syndrome." ANNALS OF HEMATOLOGY , vol.101, no.1, pp.35-41.

@article{article, author={Nazim Yildirim Et Al. }, title={Evaluation of the relationship between intravascular hemolysis and clinical manifestations in sickle cell disease: decreased hemopexin during vaso-occlusive crises and increased inflammation in acute chest syndrome}, journal={ANNALS OF HEMATOLOGY}, year=2022, pages={35-41} }